| 1. |
Jacoba CMP, Salongcay RP, Aquino LAC, et al. Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity[J]. Acta Ophthalmol, 2023, 101(6): 670-678. DOI: 10.1111/aos.15651.
|
| 2. |
Li Z, Yuan Y, Qi Q, et al. Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis[J]. Syst Rev, 2023, 12(1): 148. DOI: 10.1186/s13643-023-02321-2.
|
| 3. |
Ahmmed MS, Shuvo SD, Paul DK, et al. Prevalence of dyslipidemia and associated risk factors among newly diagnosed type-2 diabetes mellitus (T2DM) patients in Kushtia, Bangladesh[J/OL]. PLOS Glob Public Health, 2021, 1(12): e0000003[2021-12-07]. https://pubmed.ncbi.nlm.nih.gov/36962092/. DOI: 10.1371/journal.pgph.0000003.
|
| 4. |
Yao L, Wang X, Zhong Y, et al. The Triglyceride-glucose index is associated with diabetic retinopathy in Chinese patients with type 2 diabetes: a hospital-based, nested, case-control study[J]. Diabetes Metab Syndr Obes, 2021, 14: 1547-1555. DOI: 10.2147/DMSO.S294408.
|
| 5. |
周卓琳, 畢春潮, 邵娟, 等. 血脂、血糖代謝水平及血壓水平與糖尿病視網膜病變的相關性分析[J]. 實用臨床醫藥雜志, 2020, 24(10): 49-52. DOI: 10.7619/jcmp.202010012.Zhou ZL, Bi CC, Shao J, et al. Analysis on correlations between blood lipid, blood glucose metabolic levels as well as blood pressure and diabetic retinopathy[J]. J Clin Med Pract, 2020, 24(10): 49-52. DOI: 10.7619/jcmp.202010012.
|
| 6. |
錢方方, 蔡珍生, 顧恬, 等. 2型糖尿病患者血清Ectodysplasin A與非酒精性脂肪性肝病相關性研究[J]. 中國全科醫學, 2023, 26(8): 911-916. DOI: 10.12114/j.issn.1007-9572.2022.0660.Qian FF, Cai ZS, Gu T, et al. Relationship between Ectodysplasin A and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Chin Gen Pract, 2023, 26(8): 911-916. DOI: 10.12114/j.issn.1007-9572.2022.0660.
|
| 7. |
中華醫學會眼科學分會眼底病學組, 中國醫師協會眼科醫師分會眼底病學組. 我國糖尿病視網膜病變臨床診療指南(2022年)——基于循證醫學修訂[J]. 中華眼底病雜志, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.Fundus Disease Group of Ophthalmological Society of Chinese Medical Association Fundus Disease Group of Ophthalmologist Branch of Chinese Medical Doctor Association. Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J]. Chin J Ocul Fundus Dis, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.
|
| 8. |
林虹, 鄭循達, 魏余琴, 等. 雅安市2型糖尿病患者血糖控制達標情況及其影響因素[J]. 華南預防醫學, 2020, 46(6): 626-629. DOI: 10.12183/j.scjpm.2020.0626.Lin H, Zheng XD, Wei YQ, et al. Control rate of blood glucose and its influencing factors in type 2 diabetes mellitus patients in Ya’an City[J]. South China J Prev Med, 2020, 46(6): 626-629. DOI: 10.12183/j.scjpm.2020.0626.
|
| 9. |
Marie L, Al-Dabbas M, Khatatbeh A, et al. Importance of early spotting of diabetic retinopathy in type 2 diabetes patients by family medicine physicians and ophthalmologists: a study in Jordan[J/OL]. Cureus, 2023, 15(1): e34342[2023-01-29]. https://pubmed.ncbi.nlm.nih.gov/36865959/. DOI: 10.7759/cureus.34342.
|
| 10. |
Imai CC, Li L, Hardie RA, et al. Adherence to guideline-recommended HbA1c testing frequency and better outcomes in patients with type 2 diabetes: a 5-year retrospective cohort study in Australian general practice[J]. BMJ Qual Saf, 2021, 30(9): 706-714. DOI: 10.1136/bmjqs-2020-012026.
|
| 11. |
Priya S, Begum N. Correlation of lipid profile with duration of diabetes and HbA1c levels in type 2 diabetes mellitus patients: a descriptive cross-sectional study[J]. SBV J Basic Clin Appl Health Sci, 2020, 3(1): 19-22. DOI: 10.5005/jp-journals-10082-02234.
|
| 12. |
郭文娟. 2型糖尿病糖化血紅蛋白與血脂檢驗意義研究[J]. 糖尿病新世界, 2022, 7(58): 58-61. DOI: 10.16658/j.cnki.1672-4062.2022.07.058.Guo WJ. Study on the significanceof glycatedHemoglobinand blood lipid test in type 2 diabetes mellitus[J]. Diabetes New World, 2022, 7(58): 58-61. DOI: 10.16658/j.cnki.1672-4062.2022.07.058.
|
| 13. |
Yang QH, Zhang Y, Zhang XM, et al. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and meta-analysis[J]. Int J Ophthalmol, 2019, 12(2): 302-311. DOI: 10.18240/ijo.2019.02.19.
|
| 14. |
Qummar S, Khan FG, Shah S, et al. Deep learning techniques for diabetic retinopathy detection[J]. Curr Med Imaging, 2020, 16(10): 1201-1213. DOI: 10.2174/1573405616666200213114026.
|
| 15. |
Kowluru RA. Diabetic retinopathy and NADPH oxidase-2: a sweet slippery road[J]. Antioxidants (Basel), 2021, 10(5): 783. DOI: 10.3390/antiox10050783.
|
| 16. |
Tabl M. Early detection of neurodegeneration in type 2 diabetic patients without diabetic retinopathy using electroretinogram and spectral-domain optical coherence tomography[J]. J Egypt Ophthalmol Soc, 2020, 113(1): 26-32. DOI: 10.2337/db16-1453.
|
| 17. |
Wasfi EI, Soliman EN, Mohammed RM, et al. Changes in retinal nerve fiber layer thickness after panretinal photocoagulation in diabetic retinopathy[J]. Egypt Retina J, 2020, 7(2): 36-40. DOI: 10.4103/erj.erj_12_20.
|
| 18. |
尹玉如, 焦萬珍, 趙博軍. 糖尿病患者視網膜神經組織變性及微血管損傷研究[J]. 中華眼底病雜志, 2022, 38(1): 27-33. DOI: 10.3760/cma.j.cn511434-20210730-00409.Yin YR, Jiao WZ, Zhao BJ. Study on retinal neurodegeneration and microvascular lesions in diabetic patients[J]. Chin J Ocul Fundus Dis, 2022, 38(1): 27-33. DOI: 10.3760/cma.j.cn511434-20210730-00409.
|
| 19. |
許亞靜, 高健, 劉倫. 相干光層析眼底血管成像術對糖尿病視網膜病變臨床前期檢測的臨床研究[J]. 臨床眼科雜志, 2020, 28(4): 308-311. DOI: 10.3969/j.issn.1006-8422.2020.04.005.Xu YJ, Gao J, Liu L. Clinical study of optical coherence tomography angiography (OCTA) for preclinical detection of diabetic retinopathy[J]. J Clin Ophthalmol, 2020, 28(4): 308-311. DOI: 10.3969/j.issn.1006-8422.2020.04.005.
|
| 20. |
王海燕, 張永紅. 糖尿病微血管病變發病機制研究進展[J]. 河北醫科大學學報, 2024, 45(5): 585-589. DOI: 10.3969/ji.ssn.1007-3205.2024.05.016.Wang HY, Zhang YH. Research progress on pathogenesis of microvascular disease in diabetes[J]. J Hebei Med Univ, 2024, 45(5): 585-589. DOI: 10.3969/ji.ssn.1007-3205.2024.05.016.
|
| 21. |
路艷艷, 楊麗, 孫小藝, 等. 血糖控制對NDR期2型糖尿病患者視網膜神經纖維層厚度的影響[J]. 中國實驗診斷學, 2022, 26(7): 971-975. DOI: 10.3969/j.issn.1007-4287.2022.07.007.Lu YY, Yang L, Sun XY, et al. Effect of blood glucose control on the thickness of retinal nerve fiber layer in type 2 diabetes patients at NDR stage[J]. Chin J Lab Diagn, 2022, 26(7): 971-975. DOI: 10.3969/j.issn.1007-4287.2022.07.007.
|